-
https://7135c6e4-fccc-4e8a-a89e-1d1e...a9d849ba53.pdf
Above is a link to the newly established Roquefort investments who are very interested in taking midkine to a new level
by looking to purchase Lyramid from Provelmare who recently purchased Lyramid from Cellmid.
Given that Cellmid still retains the patents and Lyramid has a license to access those patents any indication of a plan of
attack should be of considerable interest.
According to the above link it looks as if there is some hope of developing a Covid 19 drug with midkine antibodies that
would alleviate cytokine storms, a devastating result of contracting Covid.
I would suggest that anyone contemplating not taking advantage of available vaccines read the above link for a
summary and the science behind this approach.
Especially pages 17 to 21
-
Cellmid is to change its name to Anagenics once the ASX approves it
The new code is hopefully AN1.
Voted in at todays AGM by what can only be described as an overwhelming mandate to do so.
99.5% for.